GlassScriptPhysician profile
Jeffrey C Macaraeg
NPI 1730595158
$4,428.35
in general payments reported to CMS, 2019-2025
31 companies · $1,201 in 2025
The $1,201 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $236 · 2021: $197 · 2022: $142 · 2023: $735 · 2024: $962 · 2025: $1,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,897.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,376.71 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Grifols USA, LLC | $613.07 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $479.08 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genentech USA, INC. | $236.93 | 2019 | |
| Amgen INC. | $213.46 | 2022-2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $210.37 | 2021-2025 | Dupixent |
| Astellas Pharma US INC | $112.23 | 2021 | |
| Merck Sharp & Dohme LLC | $104.24 | 2025 | Winrevair |
| Genzyme Corporation | $96.57 | 2019-2025 | |
| Insmed, INC. | $96.04 | 2023-2025 | Arikayce |
| Harmony Biosciences LLC | $92.86 | 2023-2025 | Wakix |
| Glaxosmithkline, LLC. | $90.06 | 2019-2025 | Nucala |
| Mylan Specialty L.P. | $73.28 | 2019-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $64.78 | 2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $60.81 | 2021-2025 | Uptravi, Opsynvi, Opsumit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $60.33 | 2020-2023 | |
| Electromed, INC. | $53.98 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $52.64 | 2023 | Glassia |
| Jazz Pharmaceuticals INC. | $49.83 | 2025 | |
| Siemens Medical Solutions USA, INC. | $43.48 | 2024 | Cios Spin |
| Avadel Cns Pharmaceuticals, LLC | $34.34 | 2024-2025 | Lumryz |
| Pharming Healthcare, INC. | $31.25 | 2023 | Ruconest |
| Viatris Specialty LLC | $30.47 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $28.37 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.75 | 2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $22.95 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Circassia INC. | $19.48 | 2019 | |
| Philips North America LLC | $14.19 | 2025 | Vest Therapy Und |
| Janssen Pharmaceuticals, INC | $13.98 | 2019 | |
| Axsome Therapeutics, INC. | $13.91 | 2024 | Sunosi |
| Shire North American Group INC | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Macaraeg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.